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Binding of L-selectin to the highly glycosylated peripheral lymph node addressins (PNAd)
plays a central role in the normal recirculation of lymphocytes between the bloodstream and
the lymph node. This interaction requires correct fucosylation of the PNAd, mediated by the
recently identified fucosyltransferase-VII (Fuc-TVII). Here we show that during ontogeny Fuc-
TVII is absent at the day of birth, barely detectable on day 1, and clearly present from day 2
onwards. PNAd expression as detected by the MECA-79 antibody precedes the expression
of Fuc-TVII. Furthermore, we demonstrate that in adult mice antigenic stimulation of periph-
eral lymph nodes leads to a temporary disappearance of Fuc-TVII at days 2 and 3 after stim-
ulation, followed by a complete reappearance by day 4, while expression of MECA-79 is
never completely absent during this period. Finally, occlusion of afferent lymphatics to
peripheral lymph nodes resulted in a decreased expression of Fuc-TVII in the high endothe-
lial venules by day 5, and complete disappearance within 8 days. We conclude that the
activity of Fuc-TVII in cells of high endothelial venules is directly affected by afferent lymph
and activation processes that occur in the lymph node after antigenic stimulation. The
expression of Fuc-TVII is therefore yet another level at which the function of high endothelial
venules, and thus lymphocyte trafficking, can be regulated.





Abbreviations: HEV: High endothelial venule PNAd:
Peripheral lymph node addressins MLN: Mesenteric
lymph node PLN: Peripheral lymph node Fuc-TVII:
Fucosyltransferase-VII
1 Introduction
During lymphocyte recirculation, blood-borne lympho-
cytes continuously extravasate from the blood into sec-
ondary peripheral lymphoid organs. L-selectin, the
peripheral lymph node (PLN) homing receptor, is present
on the surface of circulating lymphocytes and plays an
essential role in the initial interaction between the lym-
phocyte and specialized cells of the post-capillary high
endothelial venules (HEV). L-selectin interacts with
carbohydrate-based ligands of peripheral lymph node
addressins (PNAd). To date three different PNAd desig-
nated GlyCAM-1, CD34 and Sgp200, have been identi-
fied on the HEV of PLN. These PNAd display an oligo-
saccharide epitope that is recognized by the function-
blocking mAb MECA-79 [1–3]. All PNAd are mucins
showing a high degree of O-glycosylation. The glycosyl-
ation of GlyCAM-1 is best characterized. The major cap-
ping group of GlyCAM-1 has been determined as 6'-
sulfo-Lewisx [4, 5], in which sialic acid and sulfate are
critical components for binding of L-selectin [6]. The sia-
lomucin CD34 is a type I transmembrane protein, which
is expressed on hematopoietic stem cells and endothe-
lium. It can be recognized by L-selectin, but only when it
is expressed as a particular HEV-glycoform [7]. The most
recently described ligand for L-selectin, Sgp200, has not
been characterized at the carbohydrate level. However, it
can be envisaged that carbohydrate structures resemb-
ling the ones on GlyCAM-1 can also be found on this
protein.
In in vitro studies concerning the biosynthetic analyses
of GlcCAM-1, it has been shown that on most N-
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Figure 1. Expression of Fuc-TVII during ontogeny. Histochemical staining of PLN using anti-Fuc-TVII polyclonal antibody. Mice
were killed at day of birth, and at 1, 2 and 30 days after birth. It is shown that at the day of birth no Fuc-TVII is present on HEV.
At day 1 after birth some HEV show slight expression of Fuc-TVII, whereas Fuc-TVII expression is obvious on all 2-day-old HEV,
and resembled the expression in adult mice.
acetyllactosamine-containing sugar chains, fucose is
present in an § (1 1 3) linkage to the N-acetylglucos-
amine residue in Gal g 1 1 4GlcNAc units [8]. It has been
suggested that fucosylation might be the final step in the
glycosylation of glycoproteins in LN, thereby making
them functionally active [8, 9].
Recently, a novel § (1 1 3)fucosyltransferase has been
identified, designated Fuc-TVII, which is exclusively
expressed on the HEV of PLN and mesenteric lymph
nodes (MLN) and in Peyer’s patches [10]. Using Fuc-TVII
knockout mice, an essential role for Fuc-TVII in the bio-
synthesis of functional HEV-associated L-selectin
ligands in LN has been demonstrated: no L-selectin-
dependent binding could be observed in Fuc-TVII-
deficient mice, and PLN are therefore severely
decreased in size [11].
The expression of PNAd is subject to several regulatory
influences as can be seen after acute antigenic stimula-
tion in the LN or after disruption of afferent lymphatics
[12, 13].
To establish whether there is a relation between Fuc-TVII
expression and the appearance of PNAd on HEV, we
studied the presence of Fuc-TVII during ontogeny, anti-
genic stimulation of LN, and after ligation of the afferent
lymphatics.
2 Results
2.1 Expression of Fuc-TVII and PNAd during
ontogeny
Ligands for L-selectin are only functionally active in
attracting lymphocytes when they are properly fucosy-
lated. The appearance of Fuc-TVII in HEV during ontog-
eny will therefore be a hallmark of active L-selectin-
dependent lymphocyte migration to peripheral LN.
Expression of this enzyme was analyzed at several time
points after birth. In addition, we studied the appearance
of PNAd recognized by MECA-79 and the HEV-specific
epitope MECA-325. It was found that the MECA-79 epi-
tope, identifying PNAd, is already expressed at low lev-
els on the abluminal side of the vessels at the day of birth
(Table 1). However, in serial sections of the same LN we
could not observe any Fuc-TVII expression (Table 1,
Fig. 1). At 1 day after birth, when MECA-79 is expressed
on the luminal aspect of all HEV, Fuc-TVII can be
detected in some HEV. Only at 2 days after birth all HEV
show expression of Fuc-TVII (Fig. 1). MECA-325 expres-
sion could be detected starting on day 1 after birth and
onwards (Table 1).
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Figure 2. Expression of Fuc-TVII on deafferentiated popliteal LN. Histochemical staining of MECA-79-epitope, MECA-325-
epitope and Fuc-TVII. Staining was performed on PLN of control mice and at day 5 or day 8 after occlusion of the afferent lymph,
as described in Sect. 4.1. It is clear that at day 5 after interruption of lymphatics expression of both Fuc-TVII and MECA-325 is
dramatically decreased, and is absent at day 8 after deafferentiation. MECA-79 staining remained on the HEV at all time points
tested. However, the localization of expression changes from the luminal side in control HEV to abluminal in deafferentiated HEV.
2.2 Expression of Fuc-TVII in deafferentiated
popliteal LN
Previously we have shown that interruption of afferent
lymph to PLN results in a strongly reduced expression of
the MECA-79 epitope [12]. In addition, we have shown
that interruption of lymphatic flow results in complete
loss of mRNA for GlyCAM-1 and loss of L-selectin-
mediated binding to HEV [14]. To determine if incoming
lymph could also affect the enzyme that is responsible
for the formation of functional L-selectin ligands, we ana-
lyzed the expression of Fuc-TVII on HEV at different time
points after interruption of lymphatic vessels. It was
found that Fuc-TVII expression on high endothelial cells
started to decrease at 5 days after deafferentiation, and
was completely absent 8 days after occlusion (Fig. 2).
Expression of the pan-endothelial marker MECA-32 did
not change after deafferentiation (not shown), as found
previously [14]. Expression of the MECA-79 epitope
diminished, but never completely disappeared from the
abluminal sides of the vessels at the time points studied,
in accordance with our earlier findings [12].
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Figure 3. Fuc-TVII expression following antigenic stimulation. PLN were isolated at several time points after antigenic stimulation
with oxazolone. Immunofluorescence double staining of PLN with MECA-79 (TRITC, left panel) and Fuc-TVII (FITC, right panel)
reveals that at day 1 after application of oxazolone, Fuc-TVII is normally expressed in vesicles at the apical site of the HEV. The
clear apical staining of Fuc-TVII was lost starting at day 2 and remained absent on day 3 after priming. The observed diffuse out-
line of the HEV (day 2, right panel) results from incomplete blockade of the bright MECA-79 TRITC label by the FITC filter. From
day 4 and onwards, apical staining of Fuc-TVII was as in control HEV.
Table 1. Expression levels of Fuc-TVII, MECA-79 and
MECA-325 on the HEV of PLN during ontogeny. The levels
of expression are indicated as follows: −: no expression; ±:
weak expression; +: high expression.
Day of
birth
Day 1 Day 2 Day 30
Fuc-TVII − ± + +
MECA-79 ± + + +
MECA-325 − ± + +
Immunohistological examination of serial sections
revealed that the MECA-325 epitope was also diminished
at day 5 after deafferentiation and absent on the HEV of
LN at day 8 after deafferentiation, as described earlier [12].
2.3 Expression of Fuc-TVII following antigenic
stimulation
It has been shown previously that during a primary
immune response the expression and secretion of two L-
selectin ligands, GlyCAM-1 and Sgp200, are strongly
reduced, while cell-associated forms of CD34 and
Sgp200 are unaffected [13]. These studies showed that
the functions of HEV are tightly regulated during an
immune response. To examine whether antigenic stimu-
lation would also affect Fuc-TVII, we carried out a histo-
chemical analysis of the LN from animals primed with
oxazolone. The 1st day after priming, immunofluores-
cence double staining of LN using MECA-79 and Fuc-
TVII revealed that all HEV, as defined by MECA-79
expression, showed Fuc-TVII expression, while no stain-
ing was observed in the LN parenchyma (Fig. 3). Similar
staining patterns were observed when Fuc-TVII and
MECA-325 were compared (not shown). Antigenic stim-
ulation led to complete disappearance of both Fuc-TVII
and MECA-325 at 2 and 3 days after priming. In contrast,
MECA-79 staining remained unchanged (Fig. 3). The
changes in Fuc-TVII and MECA-325 expression were
transient and at day 4 after stimulation the expression of
both markers was again at control level.
To evaluate at what level the expression of Fuc-TVII is
regulated, we performed in situ hybridization with a Fuc-
TVII antisense probe to detect Fuc-TVII transcripts.
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Figure 4. In situ hybridization analysis of Fuc-TVII tran-
scripts in PLN following antigenic stimulation. PLN were iso-
lated at several time points after antigenic stimulation with
oxazolone and processed for in situ hybridization. Sections
were photographed using dark field illumination. The binding
of Fuc-TVII antisense probe clearly identifies the transcripts
localized in HEV in unstimulated LN (A). At day 1 these tran-
scripts are reduced (B), and 2 days after antigenic stimula-
tion they are completely absent (C).
Fig. 4 clearly shows that the reduced expression of the
fucosyltransferase is regulated at the transcriptional
level. While Fuc-TVII transcripts are abundantly present
in control, unstimulated LN, they are rapidly down-
regulated and completely absent at 2 days after antigen
administration. No hybridization above background lev-
els could be observed with the Fuc-TVII sense probe.
2.4 Does the MECA-325 antibody recognize Fuc-
TVII?
Considering the fact that similar expression patterns of
MECA-325 and Fuc-TVII were observed both after deaf-
ferentiation and during antigenic stimulation, we wanted
to know whether the mAb MECA-325 would recognize
Fuc-TVII. We therefore stained PLN from Fuc-TVII-
deficient mice [11] with MECA-325 to see if expression
was affected. We could observe normal expression of
the antigen recognized by MECA-325 on HEV in LN
derived from Fuc-TVII-deficient mice (data not shown).
3 Discussion
In this study we focused on the enzyme that is impera-
tive for the production of functional ligands for L-selectin
on HEV in LN. We show that during ontogeny, the Fuc-
TVII protein can be detected starting 1 day after birth,
that Fuc-TVII expression in HEV is down-regulated after
interruption of afferent lymph, and that Fuc-TVII expres-
sion is temporarily down-regulated after antigenic stimu-
lation of LN. Our data show that in addition to the regula-
tion of PNAd expression, fucosylation of these PNAd by
Fuc-TVII is yet another level at which the activity of HEV
can be regulated.
During ontogeny, it was shown that expression of the
MECA-79 epitope preceded the expression of Fuc-TVII.
In addition we showed that before birth and until 0–24 h
after birth, no GlyCAM-1 is present, and mucosal
addressin cell adhesion molecule (MAdCAM)-1 is the
only primary adhesion molecule expressed on PLN HEV
via which the first colonization occurs [14, 15].
MAdCAM-1 is normally expressed on the HEV of MLN
and Peyer’s patches only, and interacts with integrin
§ 4 g 7 in a glycosylation-independent way. Our finding
that Fuc-TVII is absent at the day of birth, together with
earlier results that show little L-selectin-dependent bind-
ing to HEV at this time in ontogeny [15], supports our
hypothesis that no functional L-selectin ligands can be
made when Fuc-TVII is absent.
Our experiments showed that an ongoing immune
response also could regulate the expression of Fuc-TVII.
At 2 and 3 days after antigenic stimulation, mRNA for
Fuc-TVII was readily lost from HEV and the enzyme was
no longer detectable. This reduction in Fuc-TVII tran-
scripts shows that upon antigenic stimulation the activity
of the enzyme is controlled at the transcriptional level.
The fact that MECA-79 staining could still be observed,
even when Fuc-TVII was absent, confirms data of Malý
et al. [11] in Fuc-TVII-deficient mice. They concluded that
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the function-blocking mAb MECA-79 can recognize a
carbohydrate moiety on PNAd in the absence of fucose,
while fucose is crucial for binding of L-selectin to PNAd.
This might implicate that the blocking function of MECA-
79 is due to steric hindrance of the interaction between
L-selectin and PNAd.
Previous findings already showed that primary immune
responses could induce changes within the PLN com-
prising a loss of GlyCAM-1 expression on HEV, whereas
expression of membrane-bound CD34 and Sgp200,
both recognized by MECA-79, remains unaffected at the
HEV [13]. We would argue that the observed lack of Fuc-
TVII expression implicates that the remaining addressins
CD34 and Sgp200, which are still actively sulfated during
the immune response, as shown by Hoke et al. [13], can-
not be fucosylated properly, suggesting that they are
therefore not functional in attracting lymphocytes via
L-selectin. However, Hoke et al. [13] describe that some
L-selectin-dependent entrance of leukocytes can still
occur. This might be due to slow turnover of functionally
glycosylated CD34 and Sgp200, synthesized before
down-regulation of the Fuc-TVII enzyme. In addition,
they observed that L-selectin-IgG chimera binding to
HEV of antigen-stimulated PLN regains control levels
only at day 7 after antigenic stimulation [13], while Fuc-
TVII expression is already at control levels at day 4. This
might indicate that there is a delay of a few days
between reappearance of the Fuc-TVII enzyme and func-
tional expression of properly glycosylated PNAd.
Several studies have been performed in an attempt to
identify possible factors involved in the regulation of
PNAd expression on the HEV. A role for factors or cells in
the incoming lymph has been shown: upon interruption
of afferent lymph to PLN, a decrease in binding of lym-
phocytes to HEV could be observed [15]. Further studies
showed that deafferentiation caused a complete loss of
mRNA encoding for GlyCAM-1 and lack of L-selectin
binding to HEV in PLN [14, 16]. In contrast, CD34
remained on the HEV of deafferentiated PLN; however,
this CD34 was not able to interact with L-selectin [17].
This is in agreement with our observations, which show
that the Fuc-TVII expression, necessary for functional
fucosylation of the PNAd, disappears from the HEV 5
days after deafferentiation of the LN. The rapid changes
in HEV are consistent with the intriguing concept of a
morphological unit connecting the subcapsular sinus
and HEV, through which signals can be delivered
instantly to the perimeter of the HEV, e.g. in response to
an immunological stimulation [18, 19].
Interestingly, MECA-325 expression also changed both
after antigenic stimulation and during deafferentiation,
indicating that this HEV-specific ligand, to which no
function in the LN has been assigned so far, is regulated
by a factor in afferent lymph during an immune response.
In fact, the Fuc-TVII and MECA-325 expression followed
identical patterns, suggesting that MECA-325 mAb
could potentially recognize Fuc-TVII. However, positive
staining of HEV in PLN from Fuc-TVII knockout mice with
mAb MECA-325 showed that the antigen recognized by
MECA-325 is not Fuc-TVII.
In this particular study we investigated the involvement
of a specific fucosyltransferase in the occurrence of
functional PNAd on HEV of PLN, and we showed that
this enzyme was susceptible to regulation when changes
in LN composition occurred. Other glycosyltransferases
such as sialyl- and sulfotransferase also play an essen-
tial role in the glycosylation of the PNAd. However, these
glycosyltransferases may be essential in other glycosyla-
tion processes which are not allowed to be switched off,
and therefore might not be susceptible to regulation dur-
ing immunological responses in the LN, in contrast to
Fuc-TVII. It still remains to be determined which factor(s)
regulate the expression of Fuc-TVII in order to obtain
functionally glycosylated PNAd, and whether the PNAd
themselves are regulated concomitantly with Fuc-TVII by
the same factor(s) present in afferent lymph.
4 Materials and methods
4.1 Animals and occlusion of afferent lymphatics
BALB/c mice were purchased from Harlan-CPB Zeist, The
Netherlands, and were kept under routine laboratory condi-
tions. For ligation of the lymphatics, mice were anesthetized
by i.m. injection of 1 ? l/g body weight of a 4:3 mixture of
Aescoket (Aesculaap N. V., Gent, Belgium) and Rompun
(Bayer, Leverkusen, Germany). The operative procedure was
performed as described by Mebius et al. [12]. Briefly, popli-
teal LN were exteriorized and afferent lymphatic vessels
were severed. Efferent lymph vessels and blood vessels
emerging from the hilus were left intact. Mice were killed at
different time points after occlusion of the afferent lymphat-
ics. Before excision of the operated LN, 0.05 ml of a 10 %
India ink solution was injected into the footpad to determine
the completeness of the operation procedure. LN with intact
afferent lymphatics, as demonstrated by the uptake of ink,
were not used. The contralateral popliteal LN served as
unoperated control tissue.
4.2 Antigenic stimulation of PLN using oxazolone
Oxazolone (Sigma) was dissolved in acetone, and as a 3 %
solution applied onto the skin of the axillary, brachial and
inguinal regions of the mouse (50 ? l per region). At several
time points after application of oxazolone, mice were killed.
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PLN were removed and frozen in liquid nitrogen before stor-
age at −20 °C.
4.3 mAb and immunohistochemistry
MECA-325 (HEV differentiation antigen; [20]) and MECA-79
(PNAd; [2]) were used in a standard two-step immunoperoxi-
dase staining on frozen sections. Briefly, 5 ? m cryostat sec-
tions were air-dried overnight and fixed in acetone for
10 min. The sections were incubated for 60 min at room
temperature with MECA-79 or with MECA-325 diluted 1:10
in PBS/0.1 % BSA. After washing thoroughly in PBS, sec-
tions were treated with horseradish peroxidase-conjugated
goat anti-rat IgG/IgM (Jackson Immuno Research, San
Francisco, CA) diluted 1:150 in PBS/0.1 % BSA containing
1 % normal mouse serum (NMS). Thereafter, the slides were
incubated in 0.5 mg/ml 3,3'-diaminobenzidine tetrahydro-
chloride (DAB, Sigma) in Tris-HCl, pH 7.4, containing 0.01 %
H2O2 for 10 min, washed, and the staining was intensified by
treating the slides for 10 min with CuSO4 solution (10 % cop-
per(II)sulfate pentahydrate in physiological salt solution).
Afterwards, slides were dehydrated and embedded in Entel-
lan neu (Merck).
Anti-Fuc-TVII (antigen-affinity-purified rabbit polyclonal anti-
body directed against murine Fuc-TVII) was generated by
Smith et al. [10]. Briefly, PCR was used to amplify a segment
of the murine Fuc-TVII gene corresponding to the enzyme’s
stem and catalytic domains, using PCR primers directed to
base pairs 2194–2224 and 3053–3085. The PCR product
was subsequently cloned into an E. coli expression vector
(pET-3b), and the recombinant protein was isolated from the
bacteria by freezing and thawing the bacterial suspension.
Recombinant Fuc-TVII protein was fractionated by SDS-
PAGE, and segments of the gel containing Fuc-TVII were
excised and used subsequently as antigen for rabbit immu-
nizations. Antisera were harvested 10 days following the last
of a total of six secondary immunizations. The Fuc-TVII poly-
clonal antibody was affinity purified using a fusion protein
containing the anthranilatesynthase sequence from E. coli,
fused to the Fuc-TVII sequence. This Fuc-TVII fusion protein
was electroblotted onto a membrane and incubated with
rabbit anti-mouse Fuc-TVII antiserum. The membrane was
then washed and the bound antibody was eluted and col-
lected for immunohistochemical procedures.
In our experiments Fuc-TVII staining was performed accord-
ing to a protocol developed by Smith et al. [10]. Briefly, 5- ? m
cryostat sections of popliteal LN were air-dried for maximal
15 min after cutting, and fixed for 20 min on ice in paraform-
aldehyde (4 % paraformaldehyde dissolved in PBS at 60 °C
and immediately used after preparation). After washing with
PBS, sections were fixed in 100 % methanol for 20 min on
ice. The sections were permeabilized and washed in block-
ing solution (PBS containing 2 % normal goat serum, 0.1 %
Triton X-100 and 0.1 % Tween-20) for 20 min at room tem-
perature. Incubation of the sections with anti-Fuc-TVII was
carried out overnight at 4 °C in the blocking solution at a
concentration of 5 ? g/ml. Sections were thoroughly washed
followed by incubation with horseradish peroxidase-
conjugated swine anti-rabbit Ig (Dako) at a 1:200 dilution in
blocking solution containing 2 % NMS for 1 h at room tem-
perature. Staining was visualized using DAB and CuSO4 as
described above.
4.4 In situ hybridization procedures
In situ hybridization was performed as described previously
[10], on paraformaldehyde-fixed frozen sections of LN. The
sections were digested and acetylated and incubated with
35S-labeled RNA in sense or antisense orientation. After
hybridization the slides were treated with RNase A, and after
dehydration coated with liquid emulsion (NTB2, Kodak).
Sections were developed according to the manufacturer’s
instructions and examined with bright field and dark field
optics after staining with hematoxylin and eosin.
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